EUROCONDOR
The EUROCONDOR project is studying an innovative therapeutic strategy using eye drops to combat diabetic retinopathy, the leading cause of blindness among working-age individuals in developed countries. Funded by the European Commission under the 7th Framework Programme, the 4 year project involves 17 partners across Europe. EUROCONDOR combines expertise in endocrinology, ophthalmology and basic research together with clinical trial knowledge and know-how in diabetes advocacy.
READ MOREDiabetes
Diabetes mellitus is a chronic condition that arises when the pancreas does not produce any insulin, or not enough, or when the body cannot properly use the insulin it produces (known as insulin resistance). Insulin is a hormone produced by the pancreas that allows glucose to enter the body's cells and transforms it into energy needed for daily life. Failure to produce insulin, or of insulin to act properly, or both, leads to high blood glucose levels. This, in turn, is associated with long-term damage to the body and failure of various organs and tissues.
READ MOREDiabetic Retinopathy
Diabetic retinopathy (DR) is an eye disease that occurs in people living with diabetes, which can ultimately lead to severe loss of vision and even blindness. DR is the most common complication of diabetes. Proliferative DR and macular oedema develop at more advanced stages. Proliferative DR occurs when abnormal blood vessels form in the retina in response to lack of oxygen. Diabetic macular oedema/edema (DMO/DME), is more frequent in type 2 than type 1 diabetes and involves leakage of fluid in the macula, the central part of the retina where central vision are located.
READ MORE